AbbVie | ABBV - Pre Tax Profit

Stock Price
197.69
Daily Change
0.31 0.16%
Monthly
-7.24%
Yearly
2.16%
Q2 Forecast
194.46

AbbVie reported $4.38B in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Abbott USD 2.39B 27M Mar/2026
ALKERMES USD 100.74M 4.1M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Merck USD 6.74B 22M Sep/2025
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
United Therapeutics USD 444M 6M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Zoetis USD 887M 15M Sep/2025